| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |